Nikhil Wagle
Director, Count Me In, Broad Institute
Nikhil Wagle is an Assistant Professor of Medicine at Harvard Medical School, a medical oncologist at Dana-Farber Cancer Institute, and an associate member of the Broad Institute of MIT and Harvard. He is the Deputy Directory of the Center for Cancer Precision Medicine at Dana-Farber Cancer Institute. Dr. Wagle leads a translational research program in the field of breast cancer genomics and precision cancer medicine. The goals of his work are to better understand the biology of metastatic breast cancer and to develop new ways to overcome or prevent drug resistance in patients with advanced breast cancer. His research aims to identify characteristics of tumors that might improve clinical decision-making for patients with advanced cancer. He also leads The Metastatic Breast Cancer Project, a nationwide patient-driven research initiative that engages patients with advanced breast cancer through social media and seeks to empower them to accelerate cancer research through sharing their samples and clinical information. The project's outreach program serves to connect thousands of patients around the U.S. with metastatic breast cancer research, allowing them to participate regardless of where they live.
Related Speakers View all
![]() |
Dr. Zoltan Lohinai
Pulmonary Oncologist & Researcher at the National Ko...
|
![]() |
Corey Casper
President & CEO at Access to Advanced Health Institu...
|
![]() |
David Williams
Professor of Public Health at Harvard University
|
![]() |
David Scadden
Co-Director of the Harvard Stem Cell Institute
|
![]() |
Stephanie Lheureux
Clinician Investigator & Medical Oncologist at Princ...
|
![]() |
Marcella Nunez-Smith
Associate Dean for Health Equity Research & Professo...
|
![]() |
Dr. Daniel J. Spakowicz
Research Assistant Professor in the Division of Medi...
|
![]() |
Haiying Cheng, MD, PhD
Physician-Scientist at Albert Einstein College; Reci...
|
![]() |
Ronald Epstein
Family Medicine, Psychiatry, & Oncology Professor at...
|
![]() |
Dr. Elizabeth Jaffee
International Leader in Immune Based Therapies for P...
|
![]() |
Andy Schmeltz
Global President and General Manager, Pfizer Oncology
|
![]() |
Steven Burakoff
Dean for Cancer Innovation & Chief of Pediatric Hema...
|
![]() |
Abdullah Feroze
Neurosurgical resident, Seattle Children’s Hospital
|
![]() |
Hasini Jayatilaka
Postdoctoral Researcher at Stanford University
|
![]() |
John Brownstein
Chief Innovation Officer, Boston Children’s Hospital...
|
![]() |
Josh Allen
Director of Development at Oncoceutics, Forbes 30 Un...
|
![]() |
Dr. Laura Esserman
Surgeon & Breast Cancer Oncology Specialist at UCSF;...
|
![]() |
Lisa Cooper
Director at Johns Hopkins Center for Health Equity a...
|
![]() |
Leonard I. Zon
Cancer Genetics & Stem Cell Biology Researcher; Prof...
|
![]() |
Laurie H. Glimcher
President & CEO of Dana-Farber Cancer Institute; Can...
|